BioIVT provides high-quality biospecimens and services for research, development, and diagnostic solutions.

For effective diagnostic kit development and manufacturing, you need a reliable source of control and calibrator plasma. With our acquisition of KEYSTONE Biologicals in 2019, we now offer high first pass disease state plasma, collected from well-characterized repeat donors, which can help keep your development moving forward. With existing donors representing autoimmune, …

Learn about BioreclamationIVT's rebranding to become BioIVT.

Oncology Tissue/Tissue-Derived Specimens. Oncology Fresh Tissue. Using fresh tissue for research is the best model but getting the fresh tissue from collection to your bench is difficult.

Mutation analysis is now being used as a development and diagnostic tool for many diseases, including cancer. Using mutation analysis for specific biomarkers for patient stratification is in ever-expanding development. BioIVT supports these efforts through standard mutation analysis for lung, melanoma and colon cancers, as well as custom mutation screening on tissues and …

The use of machine-learning-based techniques in drug discovery requires copious amounts of biomedical data. At BioIVT, we have H&E images and associated data from over 30 years of biospecimen and clinical data procurement that are ready to be incorporated into your target discovery and drug development workflows.

Your research depends on having the right biospecimens and representative cohorts as controls. These controls must also be well characterized and ethically collected. High-quality biofluids and tissues increase your assay sensitivity, reduce non-specific binding and minimize false positives. We have a wide breadth of diverse and consistent control matrices, such as s erum, CSF, o …

Get the product information you need for your research with our technical content. You can learn more about our entire range of cell and gene therapy solutions with our suite of white papers, webinars, protocols and more.

Join BioIVT’s free symposium at the Mass Bio Hub in Cambridge, MA, focusing on novel in vitro ADME methodologies and the latest ICH M12 guidance. Network with researchers, explore new studies, and enhance your preclinical drug development programs.

BioIVT offers the most complete cerebrospinal fluid (CSF) solutions in the industry. With data-rich collections from clinical sites to longitudinal collections to remnants – we have access to the CSF that your research needs to move forward.